Member Info for The.Italian

I've been waiting to see what reaction there ha s been to results and presentations.looks like none. im pleased that the s/p has not fallen a bit as my immediate reaction to the results was a little negative (debt increase mainly) although there was nothing unexpected.for me the implications are that a low ball bid by DBay has become even more likely. will be interesting to see if they start accumulating again and whether they move closer to 20%, at which point i think it will be game on.

hello dougie. this view is based first on the statements in the announcements of 5/8 20 and 24/8/20 (i think the wording is identical) stating that on the assumption that the trial (11) is sufficient to convince FDA that PEBEQ serves as an appropriate measure to support a label claim, the pivotal phase111 could commence in latter half of 2020. this has i understand been supported by statements made to bignose on enquiry that the intention is to run 11 and 111 in tandem (presumably in part). i have been sceptical about this as i also understood that 11 had to be completed before111 could begin, but apparently the company has been standing by its assertion about the overlap. i hope i am recalling things correctly, but no doubt bignose will correct anything which i have got wrong. we will have to wait to see what actually happens. as to your point about the length of trial i think its very common for laymen (myself included) to underestimate significantly the time it takes to get trials going. even though this is a mall trial it's being conducted in difficult social circumstances, but perhaps most significantly they will have had to overcome the obstacle that it's probably not the most appealing trial to be involved in. its not a life threatening disease and tbh is it the sort of trial you would personally want to take part in? so i think there will have been recruitment difficulties, which is why i am pleased that they are largely on track time wise. just my thoughts and as always happy to be corrected or to hear other views.

evening bignose. good news re FDA trial.thanks for posting.agree that there may be light the end of tunnel.very much hope thy are starting p111. still find this aspect very odd, but as you say they have referenced it twice so fingers crossed. as to the wider question, i doubt they will actually try and sell off fortacin. bit like selling the golden goose just before it starts laying, but who knows.i just don't see them getting an irresistible offer( or indeed even a mildly tempting one at moment,until positive news re OTC in europe or FDA approval). could always be wrong .that said i if the DLI deal does through i certainly expect further deals/developments in that area.as you say its obviously an area of particular interest to mellon,but also because it doesn't make much sense just to have DLI in the "portfolio". you can see from the square one news how all these little companies need to tie in together to gain traction etc and to maximise potential. could be wrong on that score as well of course.

completely agree mel. too many backward looking perspectives today imo.there was never any possibility of any significant revenue in the period in question.my own view is that the suggestion that more could have been done during covid is largely without merit .the accounts period here only covered 3 1/2 to 4 months of uk and us lockdown. to suggest that this could have been capitalised upon doesn't strike me as very realistic, given the constraints under which people were and are functioning and the lead in time necessary to set things up.i agree thata large amount of time will have been devoted to the napster linkup, which i am confident will produce results in due course. im not suggesting the are no potential problems or issues (quality of artists for live shows being one concern for me ) but i am hoping the napster deal and the increased substance this will bring to the business will start to address these concerns.

spot on keith imo. going to be a very different company in the not too distant future.

spot on keith imo.going to be a very different company in the not too distant future.

fair enough LF.fingers crossed as you say.gla

well i would be delighted if there was a substantial increase in revenue but first the interims only go up to 30th june and second the majority of the content during that period was, i think, free. hope i am wrong but I'm nor remotely concerned at this point about historic revenue. napster will be game changing in terms of revenue ,so revenue will in due course sort itself out. it's the overall direction of travel and the napster synergy which i most looking forward to discovering in due course.

evening LF. not worried as one thing we can be certain of is that whatever the content the s/p won't change. im not expecting anything of substance in the results as such. probably very little revenue, probably fairly significant expenditure etc. what will be interesting is if there is any form of update re napster. again i am not expecting any in advance of the admission document, but there may perhaps be something of interest.we shall see.

we do have results tomorrow i assume.

bignose more tech issues this morning,chat not working. any way seems ok now. yes its astonishing really that they can print this tosh.how hard is it to describe the position accurately. obviously too hard for journos (or do they just accept the publicity handouts?). the blurb about regent is so palpably risible s to be almost beyond comment.anyway enough of my complaints. interesting find by POM. couldnt find much on the us company. new business of 2 years or so.no obvious connection to the many fingered mellon but who knows.sometimes these small companies can have more clout than might first appear,depending on the reputation of the people running them etc.not suggesting for a moment that that is the case here, as there is not much info on it from a quick search and i don't intend to spend any real time on it in case it all falls through.

looks like this is a new performance.we have had at least one tie in with him before (possibly two) but good to see a new one.

i agree with that mel. arden are not major league and may well soon be outgrown.hopefully not just wishful thinking.it will be interesting to see to what extent the US influence/emphasis grows over the next couple of years.

thats right. now you mention it i had to click on your id (i wondered if i was imagining it) before it reappeared. tbh i sometimes wonder why i use the LSE site as its very unreliable tech wise.when it works well i actually like the format etc and it has very reasonable L2 access, but its technical issues are very irritating.

i used to read the FT every day for about 35 years.wouldnt touch it with a bargepole now. a sad reflection on what can be laughingly called journalistic "standards" these days.

very odd bignose.your post was there yesterday as i read it several times (bit slow on the uptake I'm afraid.) it wasn't there this morning, but has now appeared .LSE are having all sorts of technical problems at the moment so its probably that, as nothing controversial,but still a bit odd.

don't get your hopes up.it's AIM

well thats convinced me!

it is still active and expires on 31st dec 2021.no idea whether if will be exercised or not .will presumably depend on the s/p over the next 14 months.

well dougie obviously none of us know and indeed never will know, whether the rise was related to the news or not. could just be a coincidence, but I'm not sure i would agree that it was not news . not exciting .certainly, but news yes imo.for an app which is all about medical data it is extremely important to be able to demonstrate to consumers that the data is secure. personally i couldn't care less about the security of my medical data,(perhaps because i don't really have any) but we live in a world now where most people, particularly the young , are obsessed with their data and its security, almost as though the "data 'is really their embodiment and if someone gains access to it then they are at serious risk (financial data is, i accept, in a different category and i share the same concerns in that regard as the general population) .therefore to be able to demonstrate a significant step in data security will,imo,be seen as very positive step for an app of this type. .also,as bigmbose suggests, the news implies the deal is till ongoing and regardless of ones personal views it my well be perceived by the investment community as a positive development. could be completely wrong of course and its just day traders but personally i think it is linked. whilst the closing price was 10% plus , at one point it was i think 22% so not really a small movement. will be interesting to see if the deal does go through whether it leads to any significant S/P movement. .my own prediction (or rather hope) is that on the deal going through we will reach 0.20hkd, which i see as the base for next upwards movement .the next upward movement , if it is indeed that, will be determined by news on both the longevity and fortacin fronts.there is news due on fortacin in next few months (china ,OTC sales start at beginning of 2021 and FDA), so we could be entering a period of positive developments. as always not holding my breath but am finding the situation more interesting now than for some time.just my musings of course.